Takeda Pharmaceutical (TAK) to Release Quarterly Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) will be issuing its quarterly earnings data before the market opens on Thursday, May 9th. Parties interested in registering for the company’s conference call can do so using this link.

Takeda Pharmaceutical Stock Down 0.6 %

Shares of Takeda Pharmaceutical stock opened at $13.28 on Wednesday. Takeda Pharmaceutical has a 1 year low of $13.01 and a 1 year high of $17.11. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.06 and a quick ratio of 0.55. The company has a market capitalization of $42.03 billion, a P/E ratio of 20.12, a price-to-earnings-growth ratio of 3.05 and a beta of 0.56. The business has a 50-day moving average of $13.85 and a two-hundred day moving average of $14.10.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.